Therapeutic Hypothermia After Cardiac Arrest

John McPherson

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

TACT2 – Does Chelation Reduce Events in Diabetic Post-MI Patients?

Canadian Collaborative Research Network

N. Singh

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

University of Minnesota

D. Yannopoulos

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

ESC 2024 Insights: Short- and Long-Term Effects of Beta-blockers on …

ESC 2024 Insights

P. Leissner

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

The 10th Annual Western New England Acute Cardiology Conference

K. Wanamaker

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

ESC 2024 Insights

M. Böttcher

ACC 2022: High Sensitivity Troponin in the Evaluation of Acute Chest…

ACC 2022 Conference Coverage

A. Jaffe